2012

Kothe, S., Muller, J.P., Bohmer, S.A., Tschongov, T., Fricke, M., Koch, S., Thiede, C., Requardt, R.P., Rubio, I. & Bohmer, F.D. (2013) Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals through K-Ras at the plasma membrane of acute myeloid leukemia cells. J Cell Sci, 126, 4746-4755.

Wundisch, T., Dieckhoff, P., Greene, B., Thiede, C., Wilhelm, C., Stolte, M. & Neubauer, A. (2012) Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology, 143, 936-942; quiz e913-934.

Thiede, C. (2012) Mutant DNMT3A: teaming up to transform. Blood, 119, 5615-5617.

Stolzel, F., Hackmann, K., Kuithan, F., Mohr, B., Fussel, M., Oelschlagel, U., Thiede, C., Rollig, C., Platzbecker, U., Schetelig, J., Illmer, T., Schaich, M., Seliger, B., Hartmann, A., Baretton, G., Zietz, C., Ehninger, G., Schrock, E. & Bornhauser, M. (2012) Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation. Transplantation, 93, 744-749.

Sockel, K., Bornhaeuser, M., Mischak-Weissinger, E., Trenschel, R., Wermke, M., Unzicker, C., Kobbe, G., Finke, J., Germing, U., Mohr, B., Greiner, J., Beelen, D., Thiede, C., Ehninger, G., Platzbecker, U., German, M.D.S. & Cooperative Transplant Study, G. (2012) Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial. Haematologica, 97, e34-35.

Sexauer, A., Perl, A., Yang, X., Borowitz, M., Gocke, C., Rajkhowa, T., Thiede, C., Frattini, M., Nybakken, G.E., Pratz, K., Karp, J., Smith, B.D. & Levis, M. (2012) Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML. Blood, 120, 4205-4214.

Schneider, F., Hoster, E., Schneider, S., Dufour, A., Benthaus, T., Kakadia, P.M., Bohlander, S.K., Braess, J., Heinecke, A., Sauerland, M.C., Berdel, W.E., Buechner, T., Woermann, B.J., Feuring-Buske, M., Buske, C., Creutzig, U., Thiede, C., Zwaan, M.C., van den Heuvel-Eibrink, M.M., Reinhardt, D., Hiddemann, W. & Spiekermann, K. (2012) Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Ann Hematol, 91, 9-18.

Platzbecker, U., Wermke, M., Radke, J., Oelschlaegel, U., Seltmann, F., Kiani, A., Klut, I.M., Knoth, H., Rollig, C., Schetelig, J., Mohr, B., Graehlert, X., Ehninger, G., Bornhauser, M. & Thiede, C. (2012) Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. Leukemia, 26, 381-389.

Pfirrmann, M., Ehninger, G., Thiede, C., Bornhauser, M., Kramer, M., Rollig, C., Hasford, J., Schaich, M. & Study Alliance, L. (2012) Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial. Lancet Oncol, 13, 207-214.

Menschikowski, M., Platzbecker, U., Hagelgans, A., Vogel, M., Thiede, C., Schonefeldt, C., Lehnert, R., Eisenhofer, G. & Siegert, G. (2012) Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells. BMC Cancer, 12, 576.

Mager, K., Wehner, R., Bahr, F., Oelschlagel, U., Platzbecker, U., Wermke, M., Shayegi, N., Middeke, J.M., Radke, J., Rollig, C., Schetelig, J., Thiede, C., Ehninger, G., Schmitz, M., Bornhauser, M. & Tuve, S. (2012) Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation. Transplantation, 93, 1270-1275.

Krumbholz, M., Karl, M., Tauer, J.T., Thiede, C., Rascher, W., Suttorp, M. & Metzler, M. (2012) Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia. Genes Chromosomes Cancer, 51, 1045-1053.

Krug, U., Koschmieder, A., Schwammbach, D., Gerss, J., Tidow, N., Steffen, B., Bug, G., Brandts, C.H., Schaich, M., Rollig, C., Thiede, C., Noppeney, R., Stelljes, M., Buchner, T., Koschmieder, S., Duhrsen, U., Serve, H., Ehninger, G., Berdel, W.E. & Muller-Tidow, C. (2012) Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study. PLoS One, 7, e52695.

Balss, J., Pusch, S., Beck, A.C., Herold-Mende, C., Kramer, A., Thiede, C., Buckel, W., Langhans, C.D., Okun, J.G. & von Deimling, A. (2012) Enzymatic assay for quantitative analysis of (D)-2-hydroxyglutarate. Acta Neuropathol, 124, 883-891.

Agrawal-Singh, S., Isken, F., Agelopoulos, K., Klein, H.U., Thoennissen, N.H., Koehler, G., Hascher, A., Baumer, N., Berdel, W.E., Thiede, C., Ehninger, G., Becker, A., Schlenke, P., Wang, Y., McClelland, M., Krug, U., Koschmieder, S., Buchner, T., Yu, D.Y., Singh, S.V., Hansen, K., Serve, H., Dugas, M. & Muller-Tidow, C. (2012) Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood, 119, 2346-2357.